Tweet
Investor Relations OverviewSee a complete quote hereNeoGenomics is a high-complexity CLIA certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry, which industry pundits estimate is growing at 20-25% per year organically. Headquartered in Fort Myers, FL, NeoGenomics has laboratories in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, hospitals and other reference laboratories throughout the United States. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. All of these testing services are widely utilized in the diagnosis and prognosis of various types of cancer. Approximately ten years ago, the World Health Organization began reclassifying cancers as genetic anomalies. This growing awareness of the genetic root behind most cancers combined with advances in technology and genetic research, including the complete sequencing of the human genome, have made possible a whole new set of tools to diagnose and treat diseases. This has opened up a vast opportunity for laboratory companies are positioned to address this growing market segment. The company services oncologists, pathologists, urologists, hospitals and reference laboratories throughout the United States offering superior service and turnaround times. NeoGenomics superior service, turn-around times and highly specialized menu of genetic testing services allows clients to provide the full suite of cancer testing services to their patients. This innovative business model allows the local pathologist to compete against national laboratories and provide better, more local care in their communities. Download our Company Overview Presentation. Recent Press Releases
For more information please contact: Steven Jones |
- NeoGenomics Laboratories. © 2011 All Rights Reserved.